Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
International Journal of Immunopathology and Pharmacology|June 11, 2011
Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cellsI Altorjay, Z Veréb, Z Serfozo, et al.
Alimentary Pharmacology & Therapeutics|November 28, 2012
Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapyT Molnár, P L Lakatos, K Farkas, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 10, 2014
MLH1 and MSH2 mutation screening in HNPCC families of Hungary - Two new MMR gene mutationsM Tanyi, J Olasz, J L Tanyi, et al.
Tissue Antigens|April 10, 2008
Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins?P L Lakatos, I Altorjay, Y Mándi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 30, 2007
NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's diseaseT Molnar, P Hofner, F Nagy, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2011
Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's diseaseL S Kiss, T Szamosi, T Molnar, et al.
Pageof 2